Chemomab Therapeutics (CMMB) Earnings
|
Expand Research on CMMB
| Next EPS Date | N/A | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +72.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +4.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/7/25  |
Q325 | N/A | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/25 |
Q225 | N/A | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/25 |
Q225 | N/A | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/8/25 |
Q225 | N/A | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/15/25 | Q125 | -$0.01 | -$0.01 | $0.00 | N/A | N/A | N/A |  | | Details | |
| 5/14/25 |
Q125 | N/A | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/25 |
Q125 | N/A | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A |
